smartbax In-Licenses Novel Gram-Negative Antibiotic From Aicuris
MUNICH, Germany, January 20, 2026 — smartbax, a biotechnology company focused on next-generation antibiotics, announced the in-licensing of a...
in-licensing
Advertisement
Advertisement
